Founded in 2015, Exo has raised more than $100 million in funding to date and is proceeding in its vision to modernize medical imaging. The company’s investors include Action Potential Venture Capital (a GlaxoSmithKline venture fund), Applied Ventures, Bold Capital, Creative Ventures, Fiscus Ventures and Reimagined Ventures – Magnetar Capital affiliates, Innovative Growth Fund, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Solasta Ventures, TDK Ventures, and Wanxiang Healthcare Investments. We recently spoke with Dr. Janusz Bryzek, Exo’s Co-Founder and Executive Chairman, about his vision for the company, current marketplace dynamics, as well as technology and business roadmap. Dr. Bryzek also shared his main lessons for entrepreneurs in the sensors and MEMS ecosystem, and a few interesting startup companies he has been tracking.